Cancer is one of the most common illnesses in modern day society. If you haven’t been affected by this disease personally then you probably know of someone who has. There are numerous medications that are available to fight the cancer, but there is one medication that reigns supreme as of today. Have you ever heard of the drug ADCETRIS? If you haven’t then just know that this medication is one of the very best in this business. ADCETRIS delivers a cell killing blow straight into cancerous cells without harming any of the good cells. Biotech Giant Seattle Genetics produces this cancer breakthrough therapy and as of today, it is being used throughout the world in up to 65 countries.
Being such a successful drug as well as a successful business, Seattle Genetics is run by Dr. Clay Siegall, whom is the president and CEO. Dr. Siegall has built the foundation of this organization through scientific innovation and as of today, Seattle Genetics has racked up more than $350 Million from the ADCETRIS medicine alone. This guy is one of the most well respected in the game and he has a long list of accomplishments such as being an author with up to 70 publications and he currently holds 15 patents. Dr. Siegall’s strong passion and perseverance for helping others is truly why this organization is at the top of the apex. Forbes ranked Seattle genetics as one of the fastest growing companies in the nation and with so many new drugs already in the pipeline, this Bothell, Washington company is looking hire another 200 employees.
Last year, former Vice President Joe Bidden stopped by company headquarters on congratulatory purposes and over the past five years, Seattle Genetics’ stock has tripled. By implementing some of the most cutting-edge methods, Seattle Genetics dominates the industry much more so than any other cancer research center in the world.